ArticleScientific reports2025
In Silico evaluation of phytoconstituents from Carica Papaya and its anti-hyperglycemic activities on high sucrose-induced oxidative stress in Drosophila melanogaster.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxidative stress plays a key role in the development of metabolic disorders, such as diabetes. This study investigated the phytoconstituents present in Carica papaya (AECP) using an in silico model, and its anti-hyperglycemic activities on high sucrose-induced oxidative stress in Drosophila melanogaster. In silico molecular docking was performed to analyze the binding potential of AECP's bioactive compounds to key diabetes targets. Flies were fed a diet containing 30% sucrose to induce oxidative stress, followed by administration of AECP at doses of 50 and 100 mg/kg for five days. Biochemical assays assessed were glucose, total thiols, catalase, glutathione S-transferase (GST), and nitric oxide. In silico analysis revealed that carpaine, myricetin 3-rhamnoside, orientin 7-O-rhamnoside, and quercetin in AECP exhibited strong binding potential to key diabetes targets (alpha-amylase, beta-glucosidase, dipeptidyl peptidase 4, PPARG, and SGLT-2)). In fruit flies, sucrose-diet significantly (p < 0.05) reduced total thiol level, and catalase and GST activities while increasing glucose and nitric oxide levels. The AECP in a dose-dependent manner significantly (p < 0.05) reversed these changes, demonstrating its antioxidant and possible anti-hyperglycemic properties. These findings suggest that AECP may be a potential therapeutic agent for mitigating oxidative stress and supports its potential use in managing diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.